Neil Brewis

Insider Reports History

Entity
Individual
Location
C/O Eddeva B920, Babraham Research Campus, Cambridge, United Kingdom
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neil Brewis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
F-star Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 0 $7.12 Mar 8, 2023 Direct
F-star Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (right to buy) 0 Mar 8, 2023 Direct

Insider Reports Filed by Neil Brewis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FSTX F-star Therapeutics, Inc. Mar 8, 2023 5 -$815K 4 Mar 9, 2023 CHIEF SCIENTIFIC OFFICER
FSTX F-star Therapeutics, Inc. Jul 29, 2022 3 $8.43K 4 Aug 2, 2022 Chief Scientific Officer
FSTX F-star Therapeutics, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Chief Scientific Officer
FSTX F-star Therapeutics, Inc. Jan 9, 2022 1 $0 4 Jan 11, 2022 Chief Scientific Officer